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Abstract
Background: The PedsQL™ Present Functioning Visual Analogue Scales (PedsQL™ VAS) were
designed as an ecological momentary assessment (EMA) instrument to rapidly measure present or
at-the-moment functioning in children and adolescents. The PedsQL™ VAS assess child self-report
and parent-proxy report of anxiety, sadness, anger, worry, fatigue, and pain utilizing six
developmentally appropriate visual analogue scales based on the well-established Varni/Thompson
Pediatric Pain Questionnaire (PPQ) Pain Intensity VAS format.
Methods: The six-item PedsQL™ VAS was administered to 70 pediatric patients ages 5–17 and
their parents upon admittance to the hospital environment (Time 1: T1) and again two hours later
(Time 2: T2). It was hypothesized that the PedsQL™ VAS Emotional Distress Summary Score
(anxiety, sadness, anger, worry) and the fatigue VAS would demonstrate moderate to large effect
size correlations with the PPQ Pain Intensity VAS, and that patient" parent concordance would
increase over time.
Results: Test-retest reliability was demonstrated from T1 to T2 in the large effect size range.
Internal consistency reliability was demonstrated for the PedsQL™ VAS Total Symptom Score
(patient self-report: T1 alpha = .72, T2 alpha = .80; parent proxy-report: T1 alpha = .80, T2 alpha
= .84) and Emotional Distress Summary Score (patient self-report: T1 alpha = .74, T2 alpha = .73;
parent proxy-report: T1 alpha = .76, T2 alpha = .81). As hypothesized, the Emotional Distress
Summary Score and Fatigue VAS were significantly correlated with the PPQ Pain VAS in the
medium to large effect size range, and patient and parent concordance increased from T1 to T2.
Conclusion: The results demonstrate preliminary test-retest and internal consistency reliability
and construct validity of the PedsQL™ Present Functioning VAS instrument for both pediatric
patient self-report and parent proxy-report. Further field testing is required to extend these initial
findings to other ecologically relevant pediatric environments.
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Patient-reported outcomes (PROs) are self-report instru-
ments that directly measure the patient's perceptions of
the impact of disease and treatment as clinical trial end-
points, and include multi-item health-related quality of
life (HRQOL) instruments, as well as single-item meas-
ures (e.g., pain visual analogue scale), daily diaries, treat-
ment adherence, and healthcare satisfaction [1,2].
Pediatric PROs must be sensitive to cognitive develop-
ment and should include both child self-report and par-
ent proxy-report to reflect their potentially unique
perspectives. However, imperfect agreement between self
and proxy report, termed cross-informant variance [3],
has been consistently documented in the PRO measure-
ment of children with chronic health conditions and
healthy children [4]. The demonstration of cross-inform-
ant variance and the general acceptance that HRQOL and
symptoms derive from an individual's perceptions [5],
indicates an essential need in pediatric symptom measure-
ment for reliable and valid pediatric patient self-report
instruments for the broadest age range possible. With this
in mind, the Pediatric Quality of Life Inventory™ (Ped-
sQL™) was conceptualized as an age-appropriate PRO for
a wide age range of children [6,7].
The PedsQL™ Measurement Model was designed as a
modular approach to measuring pediatric PROs, devel-
oped to integrate the relative merits of generic and dis-
ease-specific approaches [6]. Although other pediatric
HRQOL instruments exist, including generic measures
and disease-specific measures [8,9], it has been an explicit
goal of the PedsQL™ Measurement Model [6] to develop
and test brief measures for the broadest age group empir-
ically feasible, specifically including child self-report for
the youngest children possible. This goal was originally
articulated in empirical efforts in the 1980's to measure
pain perception in pediatric patients through the develop-
ment and testing of the Varni/Thompson Pediatric Pain
Questionnaire™ (PPQ) for children as young as 5 years of
age [10].
The PedsQL™ includes child self-report for ages 5–18 and
parent proxy-report for ages 2–18 [7,11]. The items cho-
sen for inclusion were initially derived from the measure-
ment properties of the child self-report scales, while the
parent proxy-report scales were constructed to directly
parallel the child self-report items. Thus, the development
and testing of the PedsQL™ as a pediatric PRO explicitly
emphasizes the child's perceptions. Given that the Ped-
sQL™ Measurement Model integrates generic core scales
and disease-specific symptom scales into one measure-
ment system, and that the origins of the PedsQL™ derived
from the initial conceptual model of the PPQ [10,12-14],
then a logical extension of the PedsQL™ Measurement
Model entailed the integration of at-the-moment or
present functioning visual analogue scales (VASs) based
on the PPQ's well-established age-appropriate VAS for-
mat.
Developments in ecological momentary assessment
(EMA) suggest the benefits of measuring symptoms at-
the-moment in ecologically relevant environments [15].
The measurement of present or at-the-moment function-
ing has been well established for pediatric pain intensity
using VASs for over 20 years [16,17]. As reviewed by
McGrath [18], the VAS, although deceptively simple, has
demonstrated the measurement properties necessary for a
pain symptom measure in numerous experimental and
clinical pain studies. Historically, the VAS had been used
extensively with adult pain patients because of its sensitiv-
ity and reproducibility [19], and to a lesser extent in adults
patients with mood and anxiety disorders [20]. More
recently, the VAS has been utilized as a single-item unidi-
mensional measure of fatigue [21] and global HRQOL in
adult patients [22].
As a continuous measurement scale, the VAS potentially
avoids the clustering of symptom reports that may occur
with single-item categorical response methods [23]. In
both children and adults, the pain VAS has demonstrated
excellent construct validity in postoperative medication
studies, showing the expected reduction in pain subse-
quent to analgesia intake [23-26], and in pediatric chronic
musculoskeletal pain, demonstrating the expected
increase in perceived pain intensity with greater rheumatic
disease activity [10].
A 10 cm (100 mm) line length has been found to have the
smallest measurement error in comparison to line lengths
of 5 and 20 cm [27]. In adults, vertical or horizontal VASs
exhibit extremely high correlation (r = 0.99) [28]. From a
psychophysical measurement perspective, the VAS is con-
sidered a direct scaling method and a form of cross-
modality matching in which the length of the line is
adjusted to match the intensity of the pain [18,19]. Price
et al. have investigated the measurement properties of the
VAS in a series of psychophysical studies, demonstrating
that the VAS has ratio rather than interval scale properties
[29]. Thus, in addition to properties of interval scales
which reflect equal distances in the variables being quan-
titatively ordered, the ratio scale indicates a true zero
point [30].
The VAS has been shown to be a reliable and valid PRO
measure of pediatric patients' pain intensity in children as
young as 5 years of age [10,31,32]. Using the PPQ Pain
Intensity VAS format as a template [10], we subsequently
developed the PedsQL™ Present Functioning Visual Ana-
logue Scales (PedsQL™ VAS) to measure anxiety, sadness,
anger, worry, fatigue, and pain as experienced at-the-Page 2 of 10
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larger investigation of a healing garden adjacent to a pedi-
atric cancer center, the PedsQL™ VAS demonstrated the
hypothesized findings that self-reported anxiety, sadness,
anger, worry, fatigue, and pain levels would be lower in
individuals when in the healing garden environment than
in individuals when in the hospital inpatient and clinic
environment [33]. Although these data suggest the initial
construct validity of the PedsQL™ VAS, the sample was
small and included a mixed sample of pediatric patients,
parents, and staff reports. Thus, as part of a larger architec-
ture doctoral dissertation study investigating the effects of
the hospital environment on children, the PedsQL™ VAS
were administered to pediatric patients and their parents
upon admission to their hospital room and 2 hours sub-
sequently.
The experience of hospitalization entails many of the
"precipitants" (disease, injury, stress, medical procedures)
of pain and other symptoms posited by the Biobehavioral
Model of Pediatric Pain [34,35], and as such, provides an
ecologically relevant context in which to test the prelimi-
nary reliability and validity of the PedsQL™ symptom
VASs. Hospitalized children may find the experience
stressful [36], with elevated stress responses associated
with severity of illness or injury and number of invasive
procedures [37,38]. In response to these potential stres-
sors, hospitals have developed child life programming,
including pre-hospitalization preparation and subse-
quent support immediately at the time of hospitalization
and during the hospitalization period, all intended to
ameliorate the purported negative psychological reactions
which may occur during hospitalization and the associ-
ated medical procedures [37,39].
One of the major positive changes in the typical pediatric
hospitalization experience has been in the routine imple-
mentation of a policy of open visitation rights for parents,
including overnight stays, which has resulted in parental
social support and coping guidance throughout the hospi-
talization experience, resulting in a significant attenuation
of many of the emotional distress symptoms previously
documented in the older pediatric hospitalization litera-
ture [40]. However, it might be expected that children's
reactions to the hospital experience will vary substantially
across patients, resulting in a mean reduction of symp-
toms at the group level as a result of contemporary visita-
tion policies, but probable large individual coping
differences among patients based on such factors as age,
injury or disease characteristics, and the number and types
of medical procedures administered [40].
Based on the extant pediatric hospitalization stress and
coping literature [40], we thus hypothesized pediatric
patients' emotional distress ratings would be in the lower
range of severity at the group level, but given individual
differences in coping abilities and parental support, we
hypothesized considerable variability in patient and par-
ent VAS ratings. Further, based on the previous literature
with pediatric and adult patients, we anticipated medium
to large effect size correlations between emotional distress
and fatigue with pain intensity [41-46]. We further
hypothesized mean pain VAS scores in the mild range
since the assessments were conducted prior to medical
procedures, but anticipated considerable variability given
differing disease and injury characteristics. Finally, we
expected that distress ratings would decrease over the 2-
hour interval as patients accommodated to their hospital
rooms, and that parent-child concordance on the VASs
would increase with time given parents' prototypical con-
stant presence and vigilance during the initial hospitaliza-
tion period [40]. Finally, we expected that test-retest
reliability would be attenuated during the 2-hour retest
interval in part due to this anticipated decrease in symp-
toms over time.
Method
Participants and settings
As part of a larger architecture doctoral dissertation study
on the effects of the hospital environment on pediatric
patients, all children that were admitted to the hospital in
the 5–17 age group and their parents during the recruit-
ment period were asked to participate. Seventy-five fami-
lies were approached, and 70 families agreed to
participate (93% participation rate). The reasons for
declining participation included that the child was too
emotionally upset or in pain (secondary to sickle cell ane-
mia crisis) to participate.
Seventy children and their parents completed the Ped-
sQL™ Present Functioning Visual Analogue Scales. The
children were ages 5–17 (Mean age = 10.61, S.D. = 3.54;
40 boys, 30 girls), No ethnicity data were collected. The
children were hospitalized for treatment of acute (e.g.,
infections, accidents, injuries) and chronic (e.g., cystic
fibrosis respiratory treatment, sickle cell anemia) condi-
tions as reported by the inpatient nursing staff. However,
the larger architecture doctoral dissertation study of which
these data are derived from did not have access to individ-
ual patient medical records, and thus it was not possible
to link patient characteristics regarding medical condition
to the VAS data. Pediatric patients and their parents were
approached for permission to be part of the study once
they had been admitted into their hospital room.
Pediatric patients and their parents completed the Ped-
sQL™ VAS upon admittance, after they had consented to
be part of the study, and then two hours later, before any
medical procedures were performed. Data were collected
concurrently at two sites: Scott & White Memorial Hospi-Page 3 of 10
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in Beaumont, Texas. The length of recruitment was 3
weeks for the Scott & White Memorial Hospital and 6
weeks for the Christus St. Elizabeth's Hospital. Institu-
tional Review Board approval was obtained from both of
these institutions prior to data collection.
PedsQL™ Present Functioning Visual Analogue Scales
The PedsQL™ VAS instrument contains six items that
measure anxiety, sadness, anger, worry, fatigue, and pain
at the present moment, and where derived from the Ped-
sQL™ Emotional Functioning Scale items [7] and Ped-
sQL™ Fatigue Scale items [43], as well as the Varni/
Thompson PPQ Pain Intensity VAS [10]. The PedsQL™
VAS utilizes 100 mm lines anchored at one end with a
happy face and at the other end with a sad face based on
the original PPQ VAS format. The instructions ask partici-
pants to "Please put a mark on each line that best shows
how you feel now. If you have no problem and feel fine,
put a mark at the end of the line by the happy face. If you
have some problems and do not feel that well, put a mark
near the middle of the line. If you feel very bad or have
lots of problems, put a mark by the sad face." The Ped-
sQL™ VAS Total Symptom Score is calculated by taking the
average of all six items, while the Emotional Distress Sum-
mary Score represents the mean of the anxiety, sadness,
anger, and worry items, similar to the PedsQL™ Emotional
Functioning Scale [7]. Pain and fatigue were conceptual-
ized as individual symptom items, and where included in
the Total Symptom Score.
Varni/Thompson Pediatric Pain Questionnaire VAS
The Varni/Thompson Pediatric Pain Questionnaire (PPQ)
Pain Intensity VAS measurement properties were initially
tested in pediatric rheumatology patients as young as 5
years old and their parents, demonstrating greater per-
ceived pain intensity associated with greater rheumatic
disease activity [10]. Subsequent research studies have
supported the measurement properties of the PPQ Pain
Intensity VAS internationally [12,42,47-56], including
responsiveness to treatment effects [57,58].
Statistical analysis
Test-retest reliability was evaluated by computing both
Pearson Product Moment Correlation coefficients and
Intraclass Correlations (ICC) for each item and scale from
Time 1 to Time 2. Pearson Product Moment Correlation
coefficient effect sizes are designated as small (.10–.29),
medium (.30–.49), and large (≥.50) [59]. Intraclass corre-
lations (ICC) are designated as ≤ 0.40 poor to fair agree-
ment, 0.41–0.60 moderate agreement, 0.61–0.80 good
agreement, and 0.81–1.00 excellent agreement [60,61].
Scale internal consistency reliability was determined by
calculating Cronbach's coefficient alpha [62]. Scales with
reliabilities of 0.70 or greater are recommended for com-
paring patient groups [63].
Construct validity for the PedsQL™ VAS was investigated
through an analysis of the intercorrelations among the
emotional distress and fatigue items with the benchmark
PPQ Pain Intensity VAS criterion. Computing the intercor-
relations among scales provides initial information on the
construct validity of an instrument [30]. Paired sample t-
tests were conducted to compare scores from Time I to
Time 2.
The concordance between patient self-report and parent
proxy-report was determined through computing both
Pearson Product Moment Correlation coefficients and
Intraclass Correlations (ICC) at both Time 1 and Time 2.
Given no significant differences between sites in terms of
VAS scores after a Bonferroni correction for the number of
tests conducted, data were pooled across sites. Statistical
analyses were conducted with SPSS.
Results
Descriptives
Means and standard deviations for pediatric patient self-
report and parent proxy-report across the different age
groups are presented in Table 1 for Time 1 and Time 2.
There was considerable variability at the item and scale
level, with the standard deviations exceeding the mean for
a number of the individual VAS scores, suggesting consid-
erable individual differences.
Test-retest reliability
Test-retest reliability from Time 1 to Time 2 demonstrated
mainly moderate to larger effect sizes for patient self-
report and parent proxy-report (Table 2).
Internal consistency reliability
Internal consistency reliability alpha coefficients for the
PedsQL™ VAS are presented in Table 3. The Total Symp-
tom Score and Emotional Distress Summary Score
exceeded the minimum reliability standard for group
comparison of 0.70 for the majority of patient self-report
and parent proxy-report scales.
Construct validity
Tables 4 and 5 present the correlations between PedsQL™
Present Functioning VAS items and scale scores for patient
self-report and parent proxy-report at Time 1 and Time 2.
The emotional distress and fatigue VAS ratings demon-
strated mostly significant correlations in the medium to
large effect size range with the pain VAS criterion.
Table 6 demonstrates a general trend toward lower scores
over time for patient self-report and significantly lower
scores for parent proxy-report. The Total Symptom ScorePage 4 of 10
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with the fatigue VAS the only significantly lower score at
Time 2. Most items and scales for parent proxy-report
were significantly lower at Time 2 except for the anger
VAS, which showed a nonsignficant increase at Time 2.
Parent/Child concordance
The parent/child concordance intercorrelations matrix is
shown in Tables 4 and 5 for Time 1 and Time 2, with Pear-
son correlations and ICCs in the small to medium range
at Time 1, and in the large range at Time 2.
Discussion
This study presents the preliminary test-retest and internal
consistency reliability and construct validity of the Ped-
sQL™ Present Functioning Visual Analogue Scales for anx-
iety, sadness, anger, worry, fatigue and pain. Most test-
retest reliabilities were in the large effect size range. The
majority of internal consistency reliabilities met or
exceeded the recommended minimum alpha coefficient
standard of 0.70 for group comparisons. Preliminary con-
struct validity of the PedsQL™ Present Functioning VAS
was demonstrated through the intercorrelations among
the emotional distress and fatigue VAS rating with the
well-established PPQ VAS pain intensity criterion.
Table 1: PedsQL™ Present Functioning Visual Analogue Scales Descriptives (N = 70)
Ages 5–7 (n = 18) Ages 8–12 (n = 31) Ages 13–17 (n = 21)
PedsQL
™ Items
Patient Self-Report Parent Proxy-Report Patient Self-Report Parent Proxy-Report Patient Self-Report Parent Proxy-Report
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Time 1 
Scores
Total 
Score
25.60 19.04 29.92 18.28 28.17 20.70 38.88 22.10 28.87 19.54 35.99 20.89
Emotional 
Distress 
Summary 
Score
21.60 23.82 23.76 16.90 19.31 19.48 33.77 21.73 20.86 19.67 31.37 21.55
Anxiety 
VAS
25.00 36.10 23.61 26.83 17.26 22.94 30.48 24.54 25.57 28.02 30.71 29.25
Sadness 
VAS
22.78 35.45 17.83 24.04 17.58 24.22 38.39 34.67 15.00 17.39 30.48 27.15
Anger VAS 2.22 4.92 7.22 11.40 9.42 16.59 15.23 20.22 6.90 13.82 20.95 24.52
Worry 
VAS
36.39 41.33 46.39 26.33 32.97 36.52 50.97 29.62 35.95 34.77 43.33 32.07
Fatigue 
VAS
38.89 41.50 39.17 35.16 54.19 35.59 55.32 33.96 46.90 35.93 44.52 32.94
Pain VAS 28.33 34.13 45.28 34.75 37.58 35.91 42.90 34.27 42.86 30.72 45.95 31.37
Time 2 
Scores
Total 
Score
20.65 22.21 20.62 23.78 23.02 21.58 31.48 21.81 24.56 14.68 29.29 16.15
Emotional 
Distress 
Summary 
Score
17.43 21.02 17.32 22.91 17.84 20.34 25.60 22.73 17.38 16.77 23.10 15.51
Anxiety 
VAS
13.89 26.04 18.06 28.03 15.78 24.59 23.71 25.92 17.62 22.67 23.47 23.46
Sadness 
VAS
22.78 33.96 20.83 33.62 14.68 25.91 22.10 28.04 15.00 18.44 19.52 17.60
Anger VAS 3.06 3.89 6.11 10.23 10.32 21.68 20.48 28.59 5.48 6.87 15.71 22.21
Worry 
VAS
30.00 39.78 24.28 28.03 30.48 34.98 36.13 29.12 31.43 28.95 33.57 27.21
Fatigue 
VAS
27.78 35.45 26.94 32.36 35.16 32.42 47.58 36.67 42.62 28.18 43.57 25.65
Pain VAS 26.39 37.57 27.50 37.54 31.61 32.54 38.87 32.63 35.24 25.37 39.76 23.21
Note: 0–100 VAS scores; higher values = higher symptom levels.Page 5 of 10
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sented here were collected in the context of a larger archi-
tecture doctoral dissertation study investigating the effects
of the hospital environment on children. As such, the
larger study was not specifically designed to test the meas-
urement properties or establish the validity of the Ped-
sQL™ Present Functioning VAS. For optimal testing of a
present functioning scale, it would be useful to test for
subject characteristics that might predict VAS scores, such
as injury severity and chronic health condition. Since
these data were not collected, it was not possible to sepa-
rate the patients into known groups in order to determine
whether the VAS was able to differentiate patients based
on established diagnostic criteria. The 2-hour interval was
selected to minimize the probability of the occurrence of
medical procedures which would have substantially
affected the test-retest reliability calculations. However,
the short test-retest interval may have potentially inflated
the test-retest reliability and attenuated possible changes
in scores from Time 1 to Time 2. Further, given that previ-
ous research with the PPQ Pain Intensity VAS has demon-
strated a relationship to children's coping strategies [49],
and research with adults has demonstrated a relationship
between daily recording of pain, negative mood, and per-
ceived support [64], then future research should also
study the potential covariates of at-the-moment function-
ing in pediatric patients that would inform the validation
process.
Table 3: PedsQL™ Present Functioning Scales Internal Consistency Reliability for Patient Self-Report and Parent Proxy-Report
Ages 5–7 (n = 18) Ages 8–12 (n = 31) Ages 13–17 (n = 21) Total N = 70
Patient Report
Time 1
Total Score 0.54 0.79 0.79 0.72
Emotional Distress Summary Score 0.70 0.74 0.80 0.74
Time 2
Total Score 0.79 0.84 0.71 0.80
Emotional Distress Summary Score 0.69 0.74 0.82 0.73
Parent Report
Time 1
Total Score 0.80 0.83 0.80 0.80
Emotional Distress Summary Score 0.71 0.79 0.76 0.76
Time 2
Total Score 0.84 0.81 0.78 0.84
Emotional Distress Summary Score 0.89 0.83 0.61 0.81
Table 2: PedsQL™ Present Functioning Visual Analogue Scales Test-Retest Reliability.
Item Patient Report Parent Report
Total Score .73**
.85
.65**
.79
Emotional Distress Summary Score .65**
.78
.61**
.76
Anxiety .53**
.69
.52**
.69
Sadness .53**
.70
.55**
.70
Anger .36**
.52
.74**
.84
Worry .64**
.78
.45**
.62
Fatigue .59**
.74
.53**
.69
Pain .60**
.75
.73**
.84
Patient Self-Report and Parent Proxy-Report Time 1 to Time 2 Correlations.
*p < .05, **p < .01 (2-tailed).
Note: Effect sizes are designated as small (.10–.29), medium (.30–.49), and large (≥.50) for Pearson Product Moment Correlations. Intraclass 
Correlations (ICCs) are designated as ≤ 0.40 poor to fair agreement, 0.41–0.60 moderate agreement, 0.61–0.80 good agreement, and 0.81–1.00 
excellent agreement. Intraclass Correlation Coefficients are listed in bold below Pearson Product Moment Correlations.Page 6 of 10
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adult patients demonstrates the utility of at-the-moment
assessment in disentangling the interrelationships
between such diverse constructs as pain, mood, fatigue,
coping, and social support through a daily process analy-
sis, the application of these methods and technologies to
the pediatric population will requirement measurement
instruments that are developmentally appropriate. The
PedsQL™ Present Functioning Visual Analogue Scales rep-
resent one approach to meeting that need.
Conclusion
This study demonstrates preliminary reliability and valid-
ity of the PedsQL™ Present Functioning Visual Analogue
Scales for both child self-report and parent-proxy report.
The PedsQL™ VAS was designed as a pediatric measure-
ment instrument for the ecological momentary assess-
Table 5: PedsQL™ Present Functioning Visual Analogue Scales Time 2 Correlations: Patient Self-Report Above the Diagonal, Parent 
Proxy-Report Below the Diagonal, Patient/Parent Correlations on the Diagonal
Total Emotional Anxiety Sadness Anger Worry Fatigue Pain
Total .66** .92** .70** .75** .40** .82** .69** .81**
Score .80 .96 .81 .84 .55 .83 .76 .84
Emotional .93** .58** .77** .83** .44** .88** .40** .58**
Distress Summary Score .97 .73 .86 .88 .60 .86 .52 .68
Anxiety .79** .86** .53** .49** .13 .59** .27* .46**
VAS .87 .92 .69 .66 .21 .72 .41 .61
Sadness .80** .81** .63** .43** .30* .62** .25* .54**
VAS .87 .88 .77 .60 .41 .75 .39 .69
Anger .59** .66** .37** .41** .56** .22 .16 .25*
VAS .74 .79 .53 .58 .67 .28 .21 .33
Worry .80** .85** .75** .55** .39** .60** .45** .47**
VAS .87 .90 .86 .71 .56 .74 .62 .63
Fatigue .75** .53** .46** .49** .21 .52** .60** .60**
VAS .81 .65 .61 .64 .33 .68 .75 .75
Pain .74** .53** .38** .54** .38** .39** .54** .60**
VAS .81 .65 .54 .69 .54 .56 .70 .75
. *p < .05, **p < .01 (2-tailed).
Note: Effect sizes are designated as small (.10–.29), medium (.30–.49), and large (≥.50) for Pearson Product Moment Correlations. Intraclass 
Correlations (ICCs) are designated as ≤ 0.40 poor to fair agreement, 0.41–0.60 moderate agreement, 0.61–0.80 good agreement, and 0.81–1.00 
excellent agreement. Intraclass Correlation Coefficients are listed in bold below Pearson Product Moment Correlation.
Table 4: PedsQL™ Present Functioning Visual Analogue Scales Time 1 Correlations: Patient Self-Report Above the Diagonal, Parent 
Proxy-Report Below the Diagonal, Patient/Parent Correlations on the Diagonal.”
Total Emotional Anxiety Sadness Anger Worry Fatigue Pain
Total .45** .89** .68** .71** .48** .78** .55** .74**
Score .62 .94 .78 .81 .62 .79 .62 .78
Emotional .93** .40** .81** .77** .56** .85** .19** .48**
Distress Summary Score .96 .57 .87 .86 .69 .84 .27 .60
Anxiety .75** .81** .34** .51** .34** .56** .04 .35**
VAS .84 .88 .50 .67 .43 .70 .08 .51
Sadness .75** .79** .47** .41** .38** .48** .12 .48**
VAS .82 .85 .63 .58 .48 .62 .20 .63
Anger .56** .65** .40** .44** .19 .35** .09 .23
VAS .72 .78 .55 .58 .31 .37 .11 .27
Worry .77** .81** .63** .46** .31** .38** .26* .39**
VAS .84 .86 .77 .63 .45 .54 .42 .56
Fatigue .67** .43** .30* .38** .11 .46** .19 .37**
VAS .75 .55 .45 .55 .18 .62 .32 .53
Pain .76** .57** .49** .47** .40** .41** .44** .38**
VAS .82 .68 .64 .64 .53 .57 .61 .55
*p < .05, **p < .01 (2-tailed).
Note: Effect sizes are designated as small (.10–.29), medium (.30–.49), and large (≥.50) for Pearson Product Moment Correlations. Intraclass 
Correlations (ICCs) are designated as ≤ 0.40 poor to fair agreement, 0.41–0.60 moderate agreement, 0.61–0.80 good agreement, and 0.81–1.00 
excellent agreement. Intraclass Correlation Coefficients are listed in bold below Pearson Product Moment Correlations.Page 7 of 10
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